London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
A
)
Arianna CerutiLeipzig University, Germany
)
Ana Flavia PeresBarretos Cancer Hospital, Brazil
)
Alberto MagiUniversity of Florence, Italy
)
Alimat OyawoyeNIHR BioResource, UK
)
Albert Perlas PuenteHelmholtz Munich, Germany
)
Anna WierczeikoInstitute for Human Genetics, University Medical Center Mainz, Germany
B
)
Benjamin C. ReinerUniversity of Pennsylvania, USA
)
Basharat BhatSher-e-Kashmir University of Agricultural Sciences and Technology (SKUAST), India
)
Brendan KeatingNYU Langone Health, USA
)
Ben PriceNatural History Museum, UK
C
)
Chris AlderBioinformatician, Oxford Nanopore Technologies
)
Chloé BaumPasteur Institute, France
)
Chloe GoldsmithTranslational Health Research Institute, Western Sydney University, Australia
)
Chris SeymourVP, Advanced Platform Development, Oxford Nanopore Technologies
)
Cora VacherAssociate Director, Market Segment, Oxford Nanopore Technologies
D
)
David W. DeamerUniversity of California, Santa Cruz, USA
)
Danny E. MillerUniversity of Washington, USA
E
)
Eloisa ArbustiniIRCCS Foundation Policlinico San Matteo, Italy
)
Eva Maria NovoaCentre for Genomic Regulation, Spain
)
Emma StantonEllison Institute of Technology, UK
)
Emma WhiteVP, Marketing, Oxford Nanopore Technologies
)
)
)
)
I
)
Ilaria CasconeUniversity of Naples Federico II, Italy
)
Ira DevesonGarvan Institute of Medical Research, Australia
)
Ivo GutNational Centre for Genomic Analysis, Spain
J
)
Javeria AijazIndus Hospital & Health Network, Pakistan
)
Judith BreuerUCL Institute of Child Health, UK
)
James BrayerDirector, Business Development, Nanopore Developers & Compatible Products Program, Oxford Nanopore Technologies
)
Joy GoffenaUniversity of Washington, USA
)
Jonathon HillWasatch BioLabs, USA
)
Jeff NivalaUniversity of Washington, USA
)
Jason WilliamsCold Spring Harbor Laboratory, USA
K
)
Kimberley BillingsleyNational Institutes of Health, USA
)
Kara DicksProgramme Manager, Conservation Genomics — ORG.ONE, Oxford Nanopore Technologies
)
Kieran O'NeillCanada's Michael Smith Genome Sciences Centre, Canada
)
Karen SherwoodThe University of British Columbia & Vancouver General Hospital, Canada
)
Kathy StirrupsNIHR BioResource, UK
L
)
Lucas Esteban WangePompeu Fabra University, Spain
)
Lakmal JayasingheChief Scientific Officer, Oxford Nanopore Technologies
)
Lennart KesterPrincess Máxima Center, The Netherlands
)
Laura WhiteUniversity of Colorado School of Medicine, USA
M
)
Mike ClarkThe University of Melbourne, Australia
)
Mahreen KhanThe Hospital for Sick Children, Canada
)
Morghan Lucas Medical Genetics Center, Germany
)
Megan L. NoonanWashington University School of Medicine in St. Louis, USA
)
Mashiat Mimosa University of Toronto, Canada
)
Marcel NelenUMC Utrecht, The Netherlands
)
Michelle NgMichael Smith Laboratories, Canada
)
Matilda TierneyKing’s College London, UK
)
Mrinalini WatsaSan Diego Zoo Wildlife Alliance, USA
)
Michael WileyUniversity of Nebraska Medical Center, USA
N
)
Nadia DavidsonThe Walter and Eliza Hall Institute, Australia
)
Nathaniel EdisisBoston Children's Hospital, USA
)
Nathalie KingstonNIHR BioResource, UK
)
Nick OwensUniversity of Exeter, UK
P
)
Pamela GanNalaGenetics, Singapore
)
Pauline Luise PfudererCRUK Cambridge Centre & Department of Pathology, University of Cambridge, UK
)
Patrick MurphyMarket Segment Manager for Single Cell, Oxford Nanopore Technologies
)
Prasad SarashettiA*STAR Genome Institute of Singapore, Singapore
)
Paula Saffie-AwadSanta Maria Clinic, Chile
R
)
Rafi AhmadUniversity of Inland Norway & University of Tromsø, Norway & University of Southampton, UK
)
Ruben CoolsVIB-KU Leuven, Belgium
)
Rajesh PandeyCSIR-Institute of Genomics and Integrative Biology, India
)
Rute RegoInnovPlantProtect, Portugal
)
Rosemary Sinclair DokosChief Product & Marketing Officer, Oxford Nanopore Technologies
)
Rachel Samson P.Cranfield University, UK
)
Rhys White Institute of Environmental Science and Research, New Zealand
)
Rhydian WindsorResearch Scientist, Machine Learning, Oxford Nanopore Technologies
S
)
Salvatore BenfattoDana-Farber Cancer Institute, USA
)
Sarah FramptonUniversity of Southampton, UK
)
Sarah GriffithsBioinformatics Workflow Developer, Oxford Nanopore Technologies
)
Skarphedinn HalldorssonOslo University Hospital, Norway
)
Steven HairNewcastle University, UK
)
Sissel JuulVP, Applications, Oxford Nanopore Technologies
)
Sebastian LunkeVictorian Clinical Genetics Services, Australia
)
Sean McKenzieAssociate Director, Genomic Applications Bioinformatics, Oxford Nanopore Technologies
)
Sayonika MohantaStrategic Marketing Manager — Methylation, Oxford Nanopore Technologies
)
Steven RobbinsAustralian Centre for Ecogenomics, Australia
)
Steph WilbrahamDirector, Automation Product Management, Oxford Nanopore Technologies
T
)
Thomas AlexanderUniversity of North Carolina, USA
)
Thidathip WongsurawatMahidol University, Thailand
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Sarah Frampton
)
- Job title
- Institution
- University of Southampton, UK
- Biography
Sarah Frampton works as a Postdoctoral Research Fellow in the Cancer Genomics Group at the University of Southampton. Her research focuses on leveraging long-read sequencing technologies to advance genomics research into the Fc gamma receptor locus, aiming to generate a comprehensive understanding of regulatory mechanisms that control Fc gamma receptor expression and enhance cancer immunotherapy efficacy.
- Recent publications
Frampton, S. et al. Fc gamma receptors: Their evolution, genomic architecture, genetic variation, and impact on human disease. Immunol Rev. 328(1):65-97 (2024).
DOI: 10.1111/imr.13401
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
